Holtzman DM - Search Results

1

Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?

Stanley M, Macauley SL, Holtzman DM. Stanley M, et al. Among authors: holtzman dm. J Exp Med. 2016 Jul 25;213(8):1375-85. doi: 10.1084/jem.20160493. Epub 2016 Jul 18. J Exp Med. 2016. PMID: 27432942 Free PMC article. Review.

2

Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease.

Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM. Holtzman DM, et al. J Clin Invest. 1999 Mar;103(6):R15-R21. doi: 10.1172/JCI6179. J Clin Invest. 1999. PMID: 10079115 Free PMC article.

3

In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.

Selznick LA, Holtzman DM, Han BH, Gökden M, Srinivasan AN, Johnson EM Jr, Roth KA. Selznick LA, et al. Among authors: holtzman dm. J Neuropathol Exp Neurol. 1999 Sep;58(9):1020-6. doi: 10.1097/00005072-199909000-00012. J Neuropathol Exp Neurol. 1999. PMID: 10499444

4

Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy.

Holtzman DM. Holtzman DM. J Mol Neurosci. 2001 Oct;17(2):147-55. doi: 10.1385/JMN:17:2:147. J Mol Neurosci. 2001. PMID: 11816788 Review.

5

Human and murine ApoE markedly alters A beta metabolism before and after plaque formation in a mouse model of Alzheimer's disease.

Fagan AM, Watson M, Parsadanian M, Bales KR, Paul SM, Holtzman DM. Fagan AM, et al. Among authors: holtzman dm. Neurobiol Dis. 2002 Apr;9(3):305-18. doi: 10.1006/nbdi.2002.0483. Neurobiol Dis. 2002. PMID: 11950276

6

Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's disease.

Holtzman DM, Bales KR, Paul SM, DeMattos RB. Holtzman DM, et al. Adv Drug Deliv Rev. 2002 Dec 7;54(12):1603-13. doi: 10.1016/s0169-409x(02)00158-8. Adv Drug Deliv Rev. 2002. PMID: 12453677 Review.

7

Amyloid beta and Alzheimer disease therapeutics: the devil may be in the details.

Cirrito JR, Holtzman DM. Cirrito JR, et al. Among authors: holtzman dm. J Clin Invest. 2003 Aug;112(3):321-3. doi: 10.1172/JCI19420. J Clin Invest. 2003. PMID: 12897198 Free PMC article.

8

ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.

Fagan AM, Christopher E, Taylor JW, Parsadanian M, Spinner M, Watson M, Fryer JD, Wahrle S, Bales KR, Paul SM, Holtzman DM. Fagan AM, et al. Among authors: holtzman dm. Am J Pathol. 2004 Oct;165(4):1413-22. doi: 10.1016/s0002-9440(10)63399-8. Am J Pathol. 2004. PMID: 15466405 Free PMC article.

9

Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging.

Sun SW, Song SK, Harms MP, Lin SJ, Holtzman DM, Merchant KM, Kotyk JJ. Sun SW, et al. Among authors: holtzman dm. Exp Neurol. 2005 Jan;191(1):77-85. doi: 10.1016/j.expneurol.2004.09.006. Exp Neurol. 2005. PMID: 15589514

10

The bad seed in Alzheimer's disease.

Fryer JD, Holtzman DM. Fryer JD, et al. Among authors: holtzman dm. Neuron. 2005 Jul 21;47(2):167-8. doi: 10.1016/j.neuron.2005.07.002. Neuron. 2005. PMID: 16039556 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

743 results

Search Page

Filters